Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions

Recruiting now

Conditions studied: Undifferentiated Carcinoma

In brief

The study is based on the constitution of a collection of tumor and blood samples for the development of tumoroid for functional tests to predict clinical response to treatment.

Key facts

Study ID

NCT06612827

Run by

Centre Francois Baclesse

People needed

20

Starts

2025-03-05

Expected to finish

2032-12-15

Last updated by the study team

2025-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with undifferentiated primary carcinoma (UPC) with histological and immunohistochemical evidence, validated in a local and/or national UPC multidisciplinary consultation
• Patient with indication for systemic 1st-line treatment at the time of inclusion. Treatment may already have begun at the time of inclusion, but within the limit of 2 treatment cycles administered.
• Patient with life expectancy greater than 3 months
• Patient of legal age
• Patient affiliated to a social security scheme
• Signature of informed consent prior to any specific study procedure

You may not qualify if…

• Persons deprived of their liberty or under guardianship (including curatorship)
• Pregnant or breast-feeding patient

Where it is running

• Centre François Baclesse — Caen, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.